The sickle cell treatments available before Casgevy focused on symptom management such as reducing the frequency of ...

来自Hubrecht研究所Organoid小组的研究人员发现，特定的肠道细胞，BEST4/CA7+细胞，在对引起腹泻的细菌毒素作出反应时调节电解质和水的平衡。他们的研究结果发表在《Cell Stem Cell》杂志上，表明当暴露于细胞因子干扰素-γ (IFNγ)时，这些细胞的数量大大增加，为治疗策略提供了一个有希望的靶点。

Aplastic anaemia is a rare but serious blood disorder in which the bone marrow fails to produce enough blood cells—red blood cells, white blood cells, and platelets. This condition can lead to fatig ...

Allogene Therapeutics is developing allogeneic CAR-T cells for cancer and autoimmune diseases. Read why I'm bullish on ALLO ...

Patent strengthens CVC's leading position in European CRISPR IP landscape, providing security to over 150 ERS Genomics licensees. DUBLIN and CHESTER, England, Feb. 26, 2025 /PRNew ...

present an important study that applied a high-resolution transposon-based barcoding system to show the clonal contribution of hematopoietic stem and ...

The expansion of the advanced therapy medicinal products market is primarily fueled by the increasing incidence of chronic diseases. The rising prevalence of genetic disorders and cancer, along ...

DelveInsight's Advanced Therapy Medicinal Products Market Insights report provides the current and forecast market analysis, ...

Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...

Researchers from the Organoid group at the Hubrecht Institute have found that specific gut cells, BEST4/CA7+ cells, regulate electrolyte and water balance in response to bacterial toxins that cause ...

Researchers from the Organoid group at the Hubrecht Institute have found that specific gut cells, BEST4/CA7+ cells, regulate electrolyte and water ...

YolTech Therapeutics, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, today reported positive results from ...